Both in Pharmaceuticals
Wave Life Sciences vs Collegium Pharmaceutical
Over the past year WVE returned −60.3% and COLL returned −33.9%; their daily moves had a correlation of 0.06.
WVE −60.3% COLL −33.9%Growth of $1, one year, split-adjusted
| Metric | WVE | COLL |
|---|---|---|
| Price | $3.59 | $23.80 |
| Market cap | $708.1M | $774.8M |
| Today | −1.10% | −0.96% |
| 1 month | −7.5% | +9.0% |
| 6 months | −51.0% | −30.7% |
| Year to date | −78.9% | −48.6% |
| 1 year | −56.5% | −31.6% |
| Revenue growth (YoY) | +72.9% | +6.3% |
| Gross margin | 100.0% | 86.7% |
| Net margin | −470.5% | −7.5% |
| P/E (TTM) | — | 16.2× |
| Price / sales | 10.0× | 1.0× |
| Net cash | $430.7M | -$962.1M |
| Dividend yield | — | — |
| Volatility (60d) | 62.8% | 38.6% |
| Short % of float | 17.0% | 18.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).